Purple Biotech Ltd (TLV: PPBT)
Israel
· Delayed Price · Currency is ILS · Price in ILA13.70
-0.30 (-2.14%)
Sep 12, 2024, 5:12 PM IDT
Purple Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -16.03 | -19.88 | -21.67 | -18.38 | -28 | -5.85 | Upgrade
|
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.23 | 0.24 | 0.18 | Upgrade
|
| Stock-Based Compensation | 1.11 | 1.88 | 2.41 | 2.08 | 2.65 | 1.27 | Upgrade
|
| Other Operating Activities | -3.84 | -2.39 | -0.94 | 0.45 | 14.76 | -1.04 | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | -0.49 | 1.56 | Upgrade
|
| Change in Accounts Payable | 1.47 | 1.33 | 0.8 | 0.4 | -2.36 | 0.49 | Upgrade
|
| Change in Other Net Operating Assets | -0.61 | -1.06 | 2.46 | 0.35 | -0.59 | -0.23 | Upgrade
|
| Operating Cash Flow | -17.7 | -19.93 | -16.74 | -15.25 | -12.09 | -5.58 | Upgrade
|
| Capital Expenditures | 0 | -0 | -0.03 | -0.12 | -0.16 | -0.01 | Upgrade
|
| Cash Acquisitions | - | -3.55 | - | - | 0.07 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.2 | - | - | - | Upgrade
|
| Investment in Securities | 1.06 | 16.68 | 19.66 | 10.25 | -46.55 | 1.51 | Upgrade
|
| Other Investing Activities | 0.41 | 0.76 | 0.48 | 3.27 | -2.96 | 0.15 | Upgrade
|
| Investing Cash Flow | 1.48 | 13.88 | 19.91 | 13.41 | -49.6 | -0.45 | Upgrade
|
| Long-Term Debt Repaid | - | -0.17 | -0.17 | -0.15 | -0.18 | -0.17 | Upgrade
|
| Total Debt Repaid | -0.18 | -0.17 | -0.17 | -0.15 | -0.18 | -0.17 | Upgrade
|
| Net Debt Issued (Repaid) | -0.18 | -0.17 | -0.17 | -0.15 | -0.18 | -0.17 | Upgrade
|
| Issuance of Common Stock | 6.62 | 6.56 | 1.5 | 1.76 | 47.47 | 2.64 | Upgrade
|
| Other Financing Activities | -0.93 | -0.95 | -0.22 | -0.1 | 21.2 | 2.77 | Upgrade
|
| Financing Cash Flow | 5.52 | 5.45 | 1.11 | 1.51 | 68.49 | 5.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | 0.05 | -0.15 | -0.02 | 0.06 | 0.02 | Upgrade
|
| Net Cash Flow | -10.68 | -0.54 | 4.14 | -0.36 | 6.86 | -0.78 | Upgrade
|
| Free Cash Flow | -17.7 | -19.93 | -16.76 | -15.37 | -12.25 | -5.59 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.09 | -0.09 | -0.09 | -0.11 | -0.29 | Upgrade
|
| Cash Interest Paid | 0.05 | 0.06 | 0.07 | 0.08 | 0.02 | 0.03 | Upgrade
|
| Levered Free Cash Flow | -8.88 | -10.95 | -8.71 | -7.64 | -3.55 | -4.55 | Upgrade
|
| Unlevered Free Cash Flow | -8.88 | -10.95 | -8.71 | -7.64 | -3.55 | -4.55 | Upgrade
|
| Change in Net Working Capital | -2.11 | -0.9 | -2.94 | -1.36 | -1.97 | 2.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.